Cellular senescence contributes to age-associated reduced renal regenerative capacity
Signaling pathways in cellular senescence
United States Renal Data System. 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014.
Slegtenhorst BR, et al.. Mechanisms and consequences of injury and repair in older organ transplants. Transplant 2014; 97:1091–1099.
Wang X, Bonventre JV, Parrish AR. The aging kidney: increased susceptibility to nephrotoxicity. Int J Mol Sci 2014; 15:15358–15376.
Schmitt R, Melk A. New insights on molecular mechanisms of renal aging. Am J Transplant 2012; 12:2892–2900.
Melk A. Senescence of renal cells: molecular basis and clinical implications. Nephrol Dial Transplant 2003; 18:2474–2478.
Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10:167–181.
van Deursen JM. The role of senescent cells in ageing. Nature 2014; 509:439–446.
Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585–621.
Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458–460.
Martens UM, et al.. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res 2000; 256:291–299.
Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106:661–673.
Colgin LM, et al.. Human POT1 facilitates telomere elongation by telomerase. Curr Biol 2003; 13:942–946.
Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:323–330.
Serrano M, et al.. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85:27–37.
Braun H, et al.. Cellular senescence limits regenerative capacity and allograft survival. J Am Soc Nephrol 2012; 23:1467–1473.
Wang X, et al.. Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int 2014; 85:677–685.
Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:278–285.
Fliser D, et al.. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997; 51:1196–1204.
Nadasdy T, et al.. Proliferative activity of intrinsic cell populations in the normal human kidney. J Am Soc Nephrol 1994; 4:2032–2039.
Melk A, et al.. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 2004; 65:510–520.
Berkenkamp B, et al.. In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells. PLoS ONE 2014; 9:e88071.
Melk A, et al.. Telomere shortening in kidneys with age. J Am Soc Nephrol 2000; 11:444–453.
Westhoff JH, et al.. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010; 21:327–336.
Melk A, et al.. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 2005; 5:1375–1382.
Sis B, et al.. Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int 2007; 71:218–226.
Westhoff JH, et al.. Hypertension induces somatic cellular senescence in rat and human by induction of cell cycle inhibitor p16INK4a. Hypertension 2008; 52:123–129.
Verzola D, et al.. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 2008; 295:F1563–F1573.
Kitada K, et al.. Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy. J Diabetes Complications 2014; 28:604–611.